Literature DB >> 31085489

Longitudinal assessment of hand function in individuals with multiple sclerosis.

Scott D Newsome1, Gloria von Geldern2, Haochang Shou3, Moira Baynes4, Rhul E R Marasigan5, Peter A Calabresi4, Kathleen M Zackowski6.   

Abstract

OBJECTIVE: Little is known about the frequency and severity of hand dysfunction in individuals with multiple sclerosis (MS). Hence, we sought to determine the extent that quantitative tests of hand function detect changes over time, evaluate their relationship to global disability measures, and identify predictors of hand function.
METHODS: One-hundred and forty-seven individuals with MS were included (96 women, 84 relapsing-remitting MS [RRMS]) along with 35 age-and-sex matched controls. Quantitative tests of hand function (grip strength, pinch strength, 9 hole peg test [9HPT], finger tapping) and leg strength were acquired and normalized to age and sex. Expanded Disability Status Scale (EDSS) and timed 25 foot walk were also obtained. Spearman correlations, multivariate regression models and mixed effects linear regression were used for analysis.
RESULTS: Our cohort had an EDSS of 3.6 ± 2.2 (median ± SD) and age 44.6 ± 11.9 years. Follow up time was up to 5 years. At baseline, 14/63 individuals with progressive MS (PMS) required more than twice as much time to complete the 9HPT using their dominant hand, compared to controls. Similarly, 11 individuals with PMS had less than 50% of grip strength and 6 had less than 50% of pinch strength, compared to controls. Additionally, 7 individuals with PMS were found to be at least 50% slower than controls in finger tapping. Over two years, 27/85 individuals with MS had more than 20% worsening in their 9HPT results from baseline (17 RRMS, 10 PMS) and 37/74 (20 RRMS, 17 PMS) had more than 20% worsening in their grip strength compared to baseline.
CONCLUSIONS: Hand function is commonly impaired in individuals with MS. Assessing hand dysfunction with dynamometry and the 9HPT could help improve the precision of detecting changes in hand function over time in MS, and may be more sensitive in detecting changes in PMS. These quantitative tests may be useful as outcome measures in clinical trials using neuroprotective or reparative therapies and rehabilitative interventions.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hand function; Motor control; Multiple sclerosis; Outcome measure; Rehabilitation

Mesh:

Year:  2019        PMID: 31085489      PMCID: PMC6995030          DOI: 10.1016/j.msard.2019.04.035

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  15 in total

1.  Reliability of physical functioning measures in ambulatory subjects with MS.

Authors:  Jaana Paltamaa; Heidi West; Taneli Sarasoja; Juhani Wikström; Esko Mälkiä
Journal:  Physiother Res Int       Date:  2005

2.  Reliability and validity of grip and pinch strength evaluations.

Authors:  V Mathiowetz; K Weber; G Volland; N Kashman
Journal:  J Hand Surg Am       Date:  1984-03       Impact factor: 2.230

3.  Effect of Fampridine-PR (prolonged released 4-aminopyridine) on the manual functions of patients with Multiple Sclerosis.

Authors:  Ziv Savin; Izabella Lejbkowicz; Lea Glass-Marmor; Idit Lavi; Sara Rosenblum; Ariel Miller
Journal:  J Neurol Sci       Date:  2015-12-02       Impact factor: 3.181

4.  Quantitative sensory and motor measures detect change overtime and correlate with walking speed in individuals with multiple sclerosis.

Authors:  Kathleen M Zackowski; Joseph I Wang; John McGready; Peter A Calabresi; Scott D Newsome
Journal:  Mult Scler Relat Disord       Date:  2015-01       Impact factor: 4.339

Review 5.  The multiple sclerosis functional composite: a clinically meaningful measure of disability.

Authors:  Chris H Polman; Richard A Rudick
Journal:  Neurology       Date:  2010-04-27       Impact factor: 9.910

6.  Can the ABILHAND handle manual ability in MS?

Authors:  L E Barrett; S J Cano; J P Zajicek; J C Hobart
Journal:  Mult Scler       Date:  2012-10-24       Impact factor: 6.312

7.  The finger-tapping test. A quantitative analysis.

Authors:  I Shimoyama; T Ninchoji; K Uemura
Journal:  Arch Neurol       Date:  1990-06

8.  Employment in multiple sclerosis. Exiting and re-entering the work force.

Authors:  Laura J Julian; Lea Vella; Tim Vollmer; Olympia Hadjimichael; David C Mohr
Journal:  J Neurol       Date:  2008-07-17       Impact factor: 4.849

9.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

10.  Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial.

Authors:  Edward J Fox; Clyde Markowitz; Angela Applebee; Xavier Montalban; Jerry S Wolinsky; Shibeshih Belachew; Damian Fiore; Jinglan Pei; Bruno Musch; Gavin Giovannoni
Journal:  Mult Scler       Date:  2018-11-12       Impact factor: 6.312

View more
  2 in total

Review 1.  Facing the urgency of therapies for progressive MS - a Progressive MS Alliance proposal.

Authors:  Fernando Dangond; Alexis Donnelly; Reinhard Hohlfeld; Catherine Lubetzki; Susan Kohlhaas; Letizia Leocani; Olga Ciccarelli; Bruno Stankoff; Maria Pia Sormani; Jeremy Chataway; Federico Bozzoli; Francesco Cucca; Lisa Melton; Timothy Coetzee; Marco Salvetti
Journal:  Nat Rev Neurol       Date:  2021-01-22       Impact factor: 42.937

Review 2.  Outcome measures assisting treatment optimization in multiple sclerosis.

Authors:  Gabriel Pardo; Samantha Coates; Darin T Okuda
Journal:  J Neurol       Date:  2021-08-02       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.